Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


| Molecular Weight | 390.82 g/mol |
|---|---|
| Molecular Formula | C14H23ClN6O5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 390.1418455 g/mol |
| Monoisotopic Mass | 390.1418455 g/mol |
| Topological Polar Surface Area | 167 A^2 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 528 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Valcyte |
| PubMed Health | Valganciclovir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | Valcyte contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of the L-valyl ester of ganciclovir that exists as a mixture of two diastereomers. Ganciclovir is a synthetic guanine derivative active against CMV.Valcyte is av... |
| Active Ingredient | Valganciclovir hydrochloride |
| Dosage Form | Tablet; For solution |
| Route | Oral |
| Strength | 50mg/ml; eq 450mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 2 of 4 | |
|---|---|
| Drug Name | Valganciclovir hydrochloride |
| Drug Label | Valcyte contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of the L-valyl ester of ganciclovir that exists as a mixture of two diastereomers. Ganciclovir is a synthetic guanine derivative active against CMV.Valcyte is av... |
| Active Ingredient | Valganciclovir hydrochloride |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 450mg |
| Market Status | Tentative Approval |
| Company | Ranbaxy |
| 3 of 4 | |
|---|---|
| Drug Name | Valcyte |
| PubMed Health | Valganciclovir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | Valcyte contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of the L-valyl ester of ganciclovir that exists as a mixture of two diastereomers. Ganciclovir is a synthetic guanine derivative active against CMV.Valcyte is av... |
| Active Ingredient | Valganciclovir hydrochloride |
| Dosage Form | Tablet; For solution |
| Route | Oral |
| Strength | 50mg/ml; eq 450mg base |
| Market Status | Prescription |
| Company | Hoffmann La Roche |
| 4 of 4 | |
|---|---|
| Drug Name | Valganciclovir hydrochloride |
| Drug Label | Valcyte contains valganciclovir hydrochloride (valganciclovir HCl), a hydrochloride salt of the L-valyl ester of ganciclovir that exists as a mixture of two diastereomers. Ganciclovir is a synthetic guanine derivative active against CMV.Valcyte is av... |
| Active Ingredient | Valganciclovir hydrochloride |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 450mg |
| Market Status | Tentative Approval |
| Company | Ranbaxy |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulat...
About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
About the Company : Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle manage...
About the Company : Enaltec, founded in 2006, specializes in developing and manufacturing complex, small-volume, technology-driven APIs at competitive prices, leveraging the India advantage for global...
About the Company : Anthem Biosciences is a leading contract research and innovation service provider (CRISP) in Bengaluru, India, which manufactures novel drug actives. Established in 2007, it specia...

About the Company : CALYX is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, with its manufacturing facility located in Tarapur, Maharashtra (India). The site has been su...

About the Company : We produce Active Pharmaceutical Ingredients (APIs) providing integrated full-service capabilities. Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (...

About the Company : Synthimed Labs is a leading API manufacturer recognized for its high-quality and diverse range of Active Pharmaceutical Ingredients (APIs). Their product portfolio includes a wide ...

About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
71
PharmaCompass offers a list of Valganciclovir Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valganciclovir Hydrochloride manufacturer or Valganciclovir Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valganciclovir Hydrochloride manufacturer or Valganciclovir Hydrochloride supplier.
PharmaCompass also assists you with knowing the Valganciclovir Hydrochloride API Price utilized in the formulation of products. Valganciclovir Hydrochloride API Price is not always fixed or binding as the Valganciclovir Hydrochloride Price is obtained through a variety of data sources. The Valganciclovir Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-175865-59-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-175865-59-5, including repackagers and relabelers. The FDA regulates CAS-175865-59-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-175865-59-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-175865-59-5 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-175865-59-5 supplier is an individual or a company that provides CAS-175865-59-5 active pharmaceutical ingredient (API) or CAS-175865-59-5 finished formulations upon request. The CAS-175865-59-5 suppliers may include CAS-175865-59-5 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-175865-59-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-175865-59-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of CAS-175865-59-5 active pharmaceutical ingredient (API) in detail. Different forms of CAS-175865-59-5 DMFs exist exist since differing nations have different regulations, such as CAS-175865-59-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CAS-175865-59-5 DMF submitted to regulatory agencies in the US is known as a USDMF. CAS-175865-59-5 USDMF includes data on CAS-175865-59-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CAS-175865-59-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CAS-175865-59-5 suppliers with USDMF on PharmaCompass.
A CAS-175865-59-5 CEP of the European Pharmacopoeia monograph is often referred to as a CAS-175865-59-5 Certificate of Suitability (COS). The purpose of a CAS-175865-59-5 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CAS-175865-59-5 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CAS-175865-59-5 to their clients by showing that a CAS-175865-59-5 CEP has been issued for it. The manufacturer submits a CAS-175865-59-5 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CAS-175865-59-5 CEP holder for the record. Additionally, the data presented in the CAS-175865-59-5 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CAS-175865-59-5 DMF.
A CAS-175865-59-5 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CAS-175865-59-5 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CAS-175865-59-5 suppliers with CEP (COS) on PharmaCompass.
A CAS-175865-59-5 written confirmation (CAS-175865-59-5 WC) is an official document issued by a regulatory agency to a CAS-175865-59-5 manufacturer, verifying that the manufacturing facility of a CAS-175865-59-5 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting CAS-175865-59-5 APIs or CAS-175865-59-5 finished pharmaceutical products to another nation, regulatory agencies frequently require a CAS-175865-59-5 WC (written confirmation) as part of the regulatory process.
click here to find a list of CAS-175865-59-5 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-175865-59-5 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-175865-59-5 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-175865-59-5 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-175865-59-5 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-175865-59-5 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-175865-59-5 suppliers with NDC on PharmaCompass.
CAS-175865-59-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-175865-59-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-175865-59-5 GMP manufacturer or CAS-175865-59-5 GMP API supplier for your needs.
A CAS-175865-59-5 CoA (Certificate of Analysis) is a formal document that attests to CAS-175865-59-5's compliance with CAS-175865-59-5 specifications and serves as a tool for batch-level quality control.
CAS-175865-59-5 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-175865-59-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-175865-59-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-175865-59-5 EP), CAS-175865-59-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-175865-59-5 USP).